Quality, compliance, time, and cost are all critical concerns for life science companies conducting clinical trials.
This white paper discusses the following common quality issues in clinical research as gleaned from FDA warning letters:
- Deviations from Clinical Trial Protocol
- Failure to Implement CAPA and Adhere to GCP Standards
- Inadequate Recordkeeping and Ineffective Management of Essential Documents
- Lack of Training on SOPs and Other Procedures
Offered Free by: MasterControl Inc.
See All Resources from: MasterControl Inc.
